Using Patient-reported Outcome Measures to Improve Health Care: Time for a New Approach. by Browne, JP et al.
Browne, JP; Cano, SJ; Smith, S (2017) Using Patient-reported Out-
come Measures to Improve Health Care: Time for a New Approach.
Medical care. ISSN 0025-7079 DOI: https://doi.org/10.1097/MLR.0000000000000792
Downloaded from: http://researchonline.lshtm.ac.uk/4329137/
DOI: 10.1097/MLR.0000000000000792
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-nd/2.5/
1 
 
Using patient-reported outcome measures to improve healthcare: time for a new 
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Patient-reported outcome measures (PROMs) are measures of health, quality of life and 
related constructs that come directly from patients. The importance of PROMs in 
demonstrating the benefit to patients of new health technologies is widely recognised and 
they have been endorsed by the UK’s National Institute for Health Care Excellence and the 
Food and Drug Administration in the United States. PROMs succeed within well conducted 
studies of effectiveness because it is clear how to use the information they provide. 
 
There is increasing interest in embedding PROMs within health information systems to 
compare healthcare providers and it has been claimed that this has the potential to 
transform healthcare into a more patient-centred model.1-3 PROMs have inherent 
advantages over alternative performance measures such as mortality and clinician-defined 
morbidity. They tap into the unique and authoritative insight of patients about their own 
health, avoid the conflict of interest that occurs when healthcare providers rate their own 
performance, and directly measure the extent to which the main objective of most 
interventions has been achieved: improving the patient’s health and quality of life. The 
routine collection of PROMs has already been implemented in many countries2, and it is 
clear they should have a role in healthcare intelligence. But what is that role? We contend 
that previous attempts to use routinely collected PROMs have disappointed and propose a 
shift in purpose. We focus on the use of routinely collected PROMs to compare healthcare 
providers and do not question the value of PROMs within comparative effectiveness 
research. We also do question the use of patient-reported experience measures, sometimes 
referred to as ‘PREMS’, to compare providers. 
 
4 
 
When PROMs are embedded within health information systems they are predominantly 
used to compare the performance of individual service providers,4 networks of service 
providers,5 or insurance providers.6 There are two mechanisms by which these comparisons 
are thought to improve healthcare. First, ‘value-based purchasing’, where PROMs are used 
to facilitate purchaser choices and encourage competition.7 Second, ‘audit and feedback’ 
where PROMs are used to uncover flaws in care processes and competencies.8 
 
In the United States PROMs have been used as value-based purchasing tools within the ‘star 
ratings’ of Medicare Advantage insurance plans. These influence reimbursement, physician 
bonuses and the ability of insurance plans to expand.6 In England PROMs have been used to 
compare NHS Trust performance for four common surgical procedures since 2011 and are 
also linked to financial rewards.4 The evidence base supporting these initiatives is weak and 
there has been strong resistance from experts in performance assessment to comparing 
organisations with PROMs.9  For example, an evaluation of the English PROMs Program has 
found no impact on patient outcomes10 and the whole Program is now under review.4 
PROMs were not originally developed to compare providers and they lack many of the 
attributes desirable in a performance indicator. Variation in PROMs is heavily influenced by 
patient level variables because health perceptions are influenced by factors other than the 
healthcare provider where treatment was received. Typically, less than 10% of the variation 
in PROMs is at the provider level,10 a threshold often considered the minimum requirement 
for a performance indicator.11 High patient-level heterogeneity reduces the precision of 
provider estimates, which in turn increases the sample sizes and time needed to detect 
clinically meaningful variation.11 There is evidence in some fields such as bariatric surgery 
that slightly more than 10% of variation in PROMs can be explained at the provider level but 
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even here the amount of variation that can be explained by patient-level factors is much 
higher.12 An important source of patient-level variation is the type of treatment received. In 
breast reconstruction after mastectomy, for example, patients undergoing autologous tissue 
procedures report better outcomes compared to patients who received implants alone.13 
This patient-level variation occurs within providers because breast cancer surgeons offer a 
range of options to their patients. It can be argued that surgeons should not offer implant-
only procedures to their patients but this ignores the role that the patients’ personal values 
for different outcomes play in the decision-making process. Over time, as evidence on the 
comparative effectiveness of autologous procedures emerges it is possible that a greater 
proportion of women will opt for this type of reconstruction, but this will happen because of 
analyses that quantify the value of different types of surgery, as opposed to different 
providers. Other important patient-level influences on PROMs that are beyond the control 
of the original healthcare provider include new healthcare episodes, life events and health 
behaviors such as poor adherence to rehabilitation plans. As the time from index episode to 
outcome assessment passes the influence of the original healthcare provider on outcome 
weakens and the influence of these factors grows. These factors are unlikely to be randomly 
distributed across providers and cannot be controlled for by case-mix adjustment. 
 
A broader concern relates to the effectiveness of value-based purchasing as a whole. A 2013 
review of systematic reviews found that the evidence supporting its use was not convincing, 
particularly when outcome, rather than process measures were used to quantify value.14 A 
key difficulty with value-based purchasing is the low propensity of purchasers, including 
patients15, and agents acting on their behalf16, to use publicly released healthcare 
performance data when selecting providers. In 2016, a taskforce which reviewed the NHS 
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PROMs Program concluded that patients and clinicians may not appreciate the initiative 
because data is not easily accessible or presented in ways that demonstrate relevance to 
routine care choices.4 
 
PROMs have also been used to stimulate quality improvement through the ‘audit and 
feedback’ model. Here, PROMs are aggregated to provider level and compared, but the data 
are not necessarily released to the public. Poor performers are hypothesized to have an 
intrinsic motivation to improve relative to their peers.17 This can be done through local 
investigation of flaws in care processes and competencies or by learning from providers with 
the best results.18,19 To date there is little evidence to support this use of PROMs.20,21 A 2013 
systematic review found only one study had evaluated the benchmarking of healthcare 
providers using PROMs and this found no evidence of effectiveness.22 The difficulty is not 
the audit and feedback model itself, which, unlike value-based purchasing, has a solid 
evidence base.23 The difficulty lies in the use of PROMs in isolation, which violates the core 
principles of audit and feedback. The model involves providing a recipient with a summary 
of performance over a defined time period, focusing on evidence-based practices.24 
Crucially, the feedback should relate to behavior, for example, hand hygiene practices, as 
opposed to the outcome of those practices. PROMs are outcome measures: they tell us 
whether a patient has had a good or bad outcome, not what caused that outcome. There is 
nothing in a PROM that identifies the flaws in care processes that led to poor outcome – the 
measures focus on patients’ perceptions about their health and quality of life rather than on 
the care they received. There is now a widespread agreement that audit and feedback only 
works when it identifies specific individuals or groups responsible for poor performance, 
targets specific behaviors, is based on recent performance and produces a clear action plan 
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for improvement.24 PROMs, when used in isolation, do not lend themselves to these 
specifications. They can only be used to improve the quality of individual healthcare 
providers when linked to data about their care processes and structures. To date this has 
proved very difficult and there are few credible success stories.25 This is due to the logistics 
of data linkage and the complexity of the causal pathway that determines patient level 
outcomes.25 In hip replacement, for example, there are many different organisation-level 
variables that might influence pain and function for an individual patient six months after 
surgery. Collecting only PROMs data would not help us understand whether differences in 
PROMs were due to pre-operative assessment arrangements, surgeon ability, rehabilitation 
protocols or access to post-discharge facilities. Also, PROMs take a long time to collect and 
analyse because of the need to wait until the full effects of a treatment have been 
realized.25 In hip and knee replacement, for example, PROMs cannot be collected until a 
minimum of six months after surgery because the full benefits of surgery are difficult to 
judge any earlier.26 Feedback to orthopedic surgeons is usually at least one year out of date 
by the time it is reported. This is not a reasonable length of time for an outcome measure to 
be used to improve performance given the amount of natural change in staffing and 
practice that may happen in the interim. The flaws described above are recognized by 
clinicians and are a significant impediment to the local use of PROMs in quality 
improvement activites.27 The flaws are not insurmountable and it is possible that initiatives 
with rapid feedback, comprehensive data collection and analyses that tease apart the 
relationships between local processes and outcomes, could lead to concrete and effective 
quality improvement solutions for healthcare providers. This will require considerable 
investment however, and a willingness to move beyond relying solely on the motivations of 
clinicians and providers. 
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Clearly there are substantial flaws in current approaches to the use of routinely collected 
PROMs. There are other ways we could use PROMs at both the macro and micro level which 
have a greater probability of leading to sustained improvements in health care (Table 1). 
Previously these have been considered ‘secondary uses’ of routinely collected PROMs. Our 
contention is that these uses have a much greater likelihood of improving healthcare for 
whole patient groups than using PROMs as performance measures. 
 
First, it is possible to use PROMs to quantify the independent burden of different conditions 
once comorbidity has been accounted for.28 This in turn allows us to identify conditions 
where technological advances would lead to the greatest benefit for patients, and where 
research funding should be prioritized. By linking PROMs to data on care access and 
insurance coverage it is also possible to identify the alleviation in burden that could be 
achieved by improving access to current technologies.28 
 
Second, PROMs can help us assess the real-world impact of new technologies as they diffuse 
through care systems. Such technologies are often introduced based on weak evidence, or 
based on research that is not replicated in practice.29 Routinely collected PROMs allow for a 
broad research program across different conditions and interventions and help to identify 
where technological advances are an advance over standard treatments. The Swedish Hip 
Arthroplasty Register and the Veteran’s Health Study in the United States are models for 
how PROMs can be used to perform comparative effectiveness research within large 
observational datasets.18,30 
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Third, routinely collected PROMs could be used to assess the effectiveness of major policy 
initiatives where RCT level evidence is not feasible. PROMs data have been used to 
demonstrate the impact of introducing independent providers in the English NHS31, the 
effects of introducing market competition between hospitals,32 and to compare the 
Veteran’s Health System with private managed care in the US.33  
 
Fourth, PROMs data can be used to identify conditions or interventions where substantial 
variation in patient outcome exists across providers. Rather than assume that variation 
exists it makes more sense to check first, and then use this information to guide where 
further, more intensive quality improvement initiatives should take place. The English NHS 
PROMs Program focuses on four high volume surgical procedures which all have low 
outcome variation at the provider level.10 Volume is an important consideration when 
developing quality improvement projects but should be secondary to evidence, as with 
bariatric surgery, that substantial provider level variation exists. 
 
Finally, PROMs can improve the choice of treatment plans for individual patients. The 
evidence-base supporting the use of PROMs at the individual patient level is weak.22 But the 
PROMs used in this literature were developed for group level analysis using an approach 
known as ‘Classical Test Theory’, a methodology not designed to develop measures for use 
at the individual patient-level.  These PROMs are not reliable enough to provide a precise 
estimate of a patient’s current health status,34 and they do not have the interval-level 
properties necessary to interpret the meaning of change at different points on the scale.35 
Instead, newer methods designed to track the progress of individual patients, using 
approaches such as Rasch Measurement Theory,36 or patient-reported symptom checklists37 
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should be adopted on a more widespread basis. These newer approaches allow clinicians to 
track treatment progress and tailor therapies appropriately. When used in conjunction with 
other clinical information they can be used to highlight instances where individual patients 
are unlikely to derive benefit from a treatment or where current treatment is ineffective. 
There is emerging evidence in cancer care that this approach can improve both the process 
and outcome of care.37 
 
The suggestions above will require a significant investment in data collection technology and 
training. At a macro level, they imply the routine and regular collection of PROMs with all 
patients who interact with a health system, not just small sub-groups on a once-off basis. 
Professionals and administrative staff will need practical and methodological support, 
including training, to ensure that data is collected and used properly. At present, many 
initiatives have assumed that healthcare providers will find the staff and materials to collect 
PROMs data from their own resources. There will also need to be significant investment in 
the development and standardization of electronic health record systems to accommodate 
PROMs. 
 
At a micro level, we recommend an organic, bottom-up approach to the adoption of 
PROMs. This is already happening in specific disciplines such as breast cancer surgery38 but 
there are many areas where PROMs are rarely used at the individual patient level, or the 
wrong type of PROMs are used. Policy makers should encourage the gradual adoption of 
modern PROMs through pilot projects in collaboration with psychometric experts rather 
than impose a standardized approach. 
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Our core message is that the existing focus on using routinely collected PROMs to compare 
providers is unlikely to produce benefits for patients and needs to change. We are not 
suggesting that such comparisons will never be useful: it is possible that PROMs may 
eventually become a useful way to benchmark healthcare providers in areas with 
substantial provider-level variation, and where other information about the processes of 
care can be easily linked to PROMs to pinpoint the causes of poor performance. Until these 
conditions are met the use of PROMs to compare providers should be treated as a new 
technology with little evidence of effectiveness and the potential to be harmful. National 
performance measurement systems can lead to many unintended and harmful 
consequences such as inequality of access, erosion of trust and damaged staff morale.39 
Such systems should be introduced very carefully and only when the benefits outweigh the 
harms. We urge policy makers to continue with initiatives such as the English NHS 
Programme but to shift the focus of analysis away from provider comparisons. At present, 
we believe it would be more useful to focus on other sources of variation if the full potential 
of routinely collected PROMs is to be realized. 
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